Alongside the heads of Hospitals, Health care Institutions & Medical Universities, he also interacted with the Doctors, faculty & students. In order to build a viable model, Neeraj knew that he had to embrace the thoughts of market experts and align his idea with the medical fraternity. ![]() Additionally, his close association with the cream layer of the Industry, wide exposure all around the global market and propensity to envisage the right business opportunity – have complemented his vision. His natural flair for thinking big, robust and never exhausting energy, belief, and willpower to achieve are chiefly responsible for the sprouting of this unique concept. With a mission to bridge the gap between resource limited areas with advanced healthcare technologies in India, Neeraj has laid the foundation of Genes2Me. An affluent speaker, he is regularly invited by different media houses to speak on topics like the future of Healthcare, personalized medicines, Technology, etc. He is also an active speaker in FICCI and CII healthcare and technology conferences and meetings. Neeraj has travelled extensively throughout the globe and has been the business partner for global brands like Thermo Fisher, Nanostring, Perkin Elmer, Oxford Nanopore, Pacific Bio, Merck, Agena, etc in India. ![]() Being at the forefront of managing Genes2Me, he also holds a position in the Board of Directors in Imperial Life Sciences Pvt Ltd. His proficiency on a variety of subjects and expertise plays an instrumental role in the organization. Being in the business for over two decades, he has excellent knowledge about the market, products, and customers. Neeraj Gupta is a man with multi-faceted excellence. An NABL accredited and ISO certified lab, accuracy, and reliability is what the company banks on.Īs the Founder and CEO of Genes2Me Pvt. With a vision to transform “Genetics for the Billion”, GENES2ME aims to create a center of excellence in precision genetic testing and analysis by continually improving its services. Headquartered in Gurgaon, Genes2Me is a leading company in Genetic Screening and Molecular Diagnostics services and is offering world-class services since last four years. The company is committed to transform the diagnostics services that will be a step ahead in shaping the future of the healthcare industry. One holistic diagnostics services provider that has surpassed all expectations and has risen to the spotlight is Genes2Me Pvt. Indian scientists, medical experts, entrepreneurs, Government, and other dedicated institutions are on the trajectory to explore new technology and treatment therapies in the healthcare industry. As the integrity of the reports is the sole criterion to decide the future treatment, it’s quite important to have such diagnostics centers that truly align with the medical ethics and global standards. ![]() Molecular genetics interphase in Situ hybridization, analyse 100-300 cellsĬhromosome analysis additional karyotypes, each studyĬhromosome analysis additional specialized banding technique (eg.Diagnostics services play a pivotal role in defining the medical path for any patient. Molecular genetics interphase in Situ hybridization, analyse 25-99 cells Molecular genetics chromosomal in Situ hybridization, analyse 10-30 cells (eg. ![]() Molecular genetics chromosomal in Situ hybridization, analyse 3-5 cells (eg. diepoxybutane, mitomycin C, ionizing radiation, UV radiation)Ĭhromosome analysis count 5 sells, 1 karyotype, with bandingĬhromosome analysis count 15-20 cells, 2 karyotypes, with bandingĬhromosome analysis count 45 cells for mosaicism, 2 karyotypes, with bandingĬhromosome analysis amniotic fluid or chorionic villus, count 15 cells, 1 karyotype, with bandingĬhromosome analysis in Situ for amniotic fluid cells, count cells from 6-12 colonies, 1 karyotype, with banding for ataxia telangiectasia, Fanconi anemia, fragile X)Ĭhromosome analysis for breakage syndromes baseline SCE, score 100 cells, clastogen stress (eg. Thawing and expansion of frozen cells, each aliquotĬhromosome analysis for breakage syndromes baseline Sister Chromatid Exchange (SCE), score 20-25 cellsĬhromosome analysis for breakage syndromes baseline SCE, score 50-100 cells, count 20 cells (2 karyotypes) (eg. Tissue culture for non-neoplastic disorders solid tumorĬryopreservation freezing and storage of cells, each cell line Tissue culture for non-neoplastic disorders bone marrow, blood cells Tissue culture for non-neoplastic disorders amniotic fluid or chorionic villus cells Tissue culture for non-neoplastic disorders skin or other solid tissue biopsy Tissue culture for non-neoplastic disorders lymphocyte
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |